Nesivine Sine Conservans (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it binds to alpha‑1 and alpha‑2 receptors on vascular smooth muscle, causing vasoconstriction. This reduces blood flow to the nasal lining, decreasing edema and allowing the airway to open.

The exact dose is determined by a prescriber based on the patient’s age, condition and response. Typically, adults may use one or two sprays per nostril every 10‑12 hours, not exceeding the maximum daily frequency indicated on the product label.

Safety data for oxymetazoline in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should discuss use with their healthcare professional, who can weigh potential benefits against any uncertain risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older decongestants such as phenylephrine, oxymetazoline provides a longer duration of action (up to 12 hours) and a more potent vasoconstrictive effect. However, all topical decongestants share a risk of rebound congestion if used beyond the recommended short‑term period.

Store the nasal spray at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use to maintain product integrity.

The spray is applied directly into each nostril. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle, and press down to deliver the recommended number of sprays. Avoid inhaling sharply to prevent the medication from reaching the throat.

Serious adverse events, though rare, include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, significant rise in blood pressure, tachycardia, and severe allergic reactions such as anaphylaxis. If any of these occur, discontinue use and seek medical attention promptly.

Individuals with known hypersensitivity to oxymetazoline or any formulation ingredient should avoid the product. It is also contraindicated in patients taking monoamine oxidase inhibitors, those with severe hypertension, or anyone advised by a clinician to limit vasoconstrictive agents.